Decreased DNA repair but normal apoptosis in ultraviolet-irradiated skin of p53-transgenic mice

American Journal of Pathology

Volumn 148, Issue 4, 1996, Pages 1113-1123

  Li, Gang ^a,d   Mitchell, David L ^b   Ho, Vincent C ^a   Reed, John C ^c   Tron, Victor A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TEXAS   (United States)

^c BURNHAM INSTITUTE   (United States)

^d BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DEATH; DNA DAMAGE; DNA REPAIR; GENOTOXICITY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; SKIN TUMOR; TRANSGENIC MOUSE; ULTRAVIOLET IRRADIATION;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DNA REPAIR; GENE EXPRESSION REGULATION; GENES, P53; KERATINOCYTES; MICE; SKIN; ULTRAVIOLET RAYS;

EID: 0029922051     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene Nature 1991, 351:453-456
2. Oren M. p53: the ultimate tumor suppressor gene? FASEB J 1992, 6:3169-3176
3. Takahashi T, Carbone D, Takahashi T, Nau MM, Hida T, Linniola I, Ueda R, Minna JD: Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res 1992, 52:2340-2343
4. Casey G, Lo-Hsueh M, Lopez ME, Vogelstein B, Stanbridge EJ: Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene 1991, 6 1791-1797
5. Baker S, Markowitz S, Fearon ER, Willson JKV, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990, 249: 912-915
6. Halevy O, Michalovitz D, Oren M. Different tumor-derived p53 mutants exhibit distinct biological activities Science 1990, 250 113-116
7. Hollstein M, Sidransky D, Vogelstein B, Harris CC p53 mutations in human cancers. Science 1991, 253:49-53
8. Lee JM, Abrahamson JLA, Bernstein A: DNA damage, oncogenesis, and the p53 tumour-suppressor gene Mutat Res 1994, 307:573-581
9. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage Cancer Res 1991, 51:6304-6311
10. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr. A mammalian cell cycle checkpoint pathway Cell 1992, 71:587-597
11. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB: Wildtype p53 is a cell cycle checkpoint determinant following irradiation Proc Natl Acad Sci USA 1992, 89:7491-7495
12. Lu X, Lane DP: Differential induction of transcriptionally active p53 following UV or ionizing radiation. defects in chromosome instability syndromes? Cell 1993, 75:765-778
13. Hall PA, McKee PH, Menage HD, Dover R, Lane, DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993, 8:203-207
14. Caelles C, Helmberg A, Karin M: p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994, 370:220-223
15. Smith ML, Chen IT, Zhan Q, O'Connor PM, Fornace AJ Jr. Involvement of the p53 tumor suppressor in repair of u.v-type DNA Oncogene 1995, 10:1053-1059
16. Haffner R, Oren M. Biochemical properties and biological effects of p53. Curr Opin Genet Dev 1995, 5:84-90
17. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825
18. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816
19. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Science 1993, 366:701-704
20. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA Nature 1994, 369 574-578
21. Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM, Fornace AJ Jr: Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen Science 1994, 266:1376-1380
22. Zhan Q, Lord KA, Alamo I Jr, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA, Fornace AJ Jr The gadd and Myd genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth Mol Cell Biol 1994, 14:2361-2371
23. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994, 91:2230-2234
24. Lee JM, Bernstein A: p53 mutations increase resistance to ionizing radiation Proc Natl Acad Sci USA 1993, 90:5742-5746
25. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993, 362:849-852
26. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993, 362:847-849
27. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents Cell 1993, 74:957-967
28. Lotem J, Sachs L: Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood 1993, 82:1092-1096
29. Gottlieb E, Haffner R, von Ruden T, Wagner EF, Oren M. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal EMBO J 1994, 13 1368-1374
30. Zhu YM, Bradbury DA, Russell NH: Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells Br J Cancer 1994, 69:468-472
31. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T, Van Dyke T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 1994, 78:703-711
32. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T, Brash DE: Sunburn and p53 in the onset of skin cnacer. Nature 1994, 372:773-776
33. Reed JC Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124:1-6
34. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619
35. Pezzella F, Morrison H, Jones M, Gatter KC, Lane D, Harris AL, Mason DY. Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma Histopathology 1993, 22:39-44
36. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo Oncogene 1994, 9:1799-1805
37. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80:293-299
38. Strasser A, Harris AW, Jacks T, Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 1994, 79 329-339
39. Wang Y, Szekely L, Okan I, Klein G, Wiman KG: Wildtype p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Oncogene 1993, 8:3427-3431
40. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, Liebermann D: Immediate early up-regulation of bax expression by p53 but not TGF-β1: a paradigm for distinct apoptotic pathways Oncogene 1994, 9:1791-1798
41. Li G, Ho VC, Berean K, Tron VA: Ultraviolet radiation induction of squamous cell carcinomas in p53 transgenic mice Cancer Res 1995, 55:2070-2074
42. Mowat M, Cheng A, Kimura N, Bernstein A, Benchin S: Rearrangement of the cellular p53 gene in erythroleukemic cells transformed by Friend virus. Nature 1985, 314:633-636
43. Laviguer A, Maltby V, Mock D, Rossant J, Pawson T, Bernstein A. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 1989, 9:3982-3991
44. Hogan B, Constantini F, Lacy E (Eds): Manipulating the Mouse Embryo A Laboratory Manual Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1986. pp 174-176
45. Mitchell DL, Cleaver JE, Epstein JH: Repair of pyrimidine (6-4) pyrimidone photoproducts in mouse skin J Invest Dermal 1990, 95:55-59
46. Mitchell DL, Clarkson JM, Chao CC-K, Rosenstein BS Repair of cyclobutane dimers and (6-4) photoproducts in ICR 2A frog cells Photochem Photobiol 1986, 43 595-597
47. Mitchell DL, Vanghan JE, Nairn RS: Inhibition of transient gene expression in Chinese hamster ovary cells by cyclobutane dimers and (6-4) photoproducts in transfected UV-irradiated plasmid DNA Plasmid 1989, 21:21-30
48. Mitnhell DL, Humphrey RM, Adair GM, Thompson LH, Clarkson JM Repair of (6-4) photoproducts correlates with split-dose recovery in UV-irradiated normal and hypersensitive rodent cells. Mutat Res 1988, 193 53-63
49. Mitchell DL. Rosenstein BS: The use of specific radioimmunoassays to determine action spectra for the photolysis of (6-4) photoproducts. Photochem Photobiol 1987, 45:781-786
50. Wood WS, Tron VA: Analysis of HMB-45 immunoreactivity in common and cellular blue nevi. J Cutaneous Pathol 1991, 18:261-263
51. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 1994, 145 515-525
52. Lipponen PK, Aaltomaa S: Apoptosis in bladder cancer as related to standard prognostic factors and prognosis J Pathol 1994, 173:333-339
53. Oren M: Relationship of p53 to the control of apoptotic cell death. Semin Cancer Biol 1994, 5:221-227
54. Lane DP, Lu X, Hupp T, Hall PA: The role of the p53 protein in the apoptotic response. Philos Trans R Soc Lond-Biol Sci 1994, 345:277-280
55. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation Nature 1980, 284:555-557
56. Borner MM, Myers CE, Sartor O, Sei Y, Toko T, Trepel JB, Schneider E: Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res 1995, 55:2122-2128
57. Chiou SK, Rao L, White E Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 1994, 14:2556-2563
58. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM. Down-regulation of bcl-2 by p53 in breast cancer cells Cancer Res 1994, 54:2095-2097
59. Burns JE, Baird MC, Clark LJ, Burns PA, Edington K, Chapman C, Mitchell R, Robertson G, Soutar D, Parkinson EK: Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines Br J Cancer 1993, 67:1274-1284
60. Kress S, Christian S, Strickland PT, Mukhtar H, Schweizer J, Schwarz M Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin Cancer Res 1992, 52:6400-6403
61. Brash DE, Rudolph JA, Simon JA, Lm A, McKenna GJ, Baden HP, Halperin AJ, Ponten J. A role for sunlight in skin cancer. UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991, 88: 10124-10128
62. Rady P, Scinicaiello F, Wagner RF Jr, Tyring SK. p53 mutations in basal cell carcinomas Cancer Res 1992, 52:3804-3806
63. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L, Cho KR Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage Proc Natl Acad Sci USA 1993, 90:3988-3992
64. Gujuluva CN, Baek JH, Shinn KH, Cherrick HM, Park NH. Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes Oncogene 1994, 9:1819-1827
65. Zhan Q, Carrier F, Fornace AJ Jr: Induction of cellular p53 activity by DNA-damaging agents and growth arrest Mol Cell Biol 1993, 13:4242-4250
66. Shivji KK, Kenny MK, Wood RD: Proliferating cell nuclear antigen is required for DNA excision repair. Cell 1992, 69:367-374
67. Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly J-M, Wang Z, Friedberg EC, Evans MK, Taffe BG, Bohr VA, Weeds G, Hoeijmakers JHJ, Forrester K, Harris CC. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat Genet 1995, 10:188-195
68. Lee S, Elenbaas B, Levine A, Griffith J. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 1995, 81:1013-1020
69. Jayaraman L, Prives C Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 1995, 81:1021-1029
70. Ishizaki K, Ejuma Y, Matsunaga T, Hara R, Sakamoto A, Ikenaga M, Ikawa Y, Aizawa S: Increased UV-induced SCEs but normal repair of DNA damage in p53-deficient mouse cells. Int J Cancer 1994, 58:254-257
71. Sun Y, Dong ZG, Nakamura K, Colburn NH: Dosage-dependent dominance over wild-type p53 of a mutant p53 isolated from nasopharyngeal carcinoma FASEB J 1993, 7:944-950
72. Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP, Hall PA. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice Cancer Res 1994, 54 614-617
73. Merlo GR, Basolo F, Fiore L, Duboc L, Hynes NE p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. J Cell Biol 1995, 128:1185-1196
74. Gillardon F, Eschenfelder C, Uhlmann E, Wolfgang H, Zimmermann M: Differential regulation of c-fos, fosB, c-jun, junB, bcl-2 and bax expression in rat skin following single or chronic ultraviolet irradiation and in vivo modulation by antisense oligodeoxynucleotide super-fusion. Oncogene 1994, 9 3219-3225
75. Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM, Fornace AJ Jr: Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis Oncogene 1994, 9:3743-3751